Table of Contents
Chemotherapy Research and Practice
Volume 2010 (2010), Article ID 524629, 8 pages
http://dx.doi.org/10.1155/2010/524629
Research Article

Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?

1i3 Innovus, Medford, MA 02155, USA
2Global Health Outcomes, Lilly Corporate Center, Eli Lilly and Company, DC6831, Indianapolis, IN 46285, USA
3Boston Health Economics, Inc., Waltham, MA 02451, USA
4Institute for Clinical Evaluative Sciences, Toronto, ON, Canada M4N 3M5

Received 10 November 2009; Revised 17 May 2010; Accepted 16 June 2010

Academic Editor: Nagahiro Saijo

Copyright © 2010 Karen M. Clements et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Karen M. Clements, Gerson Peltz, Douglas E. Faries, et al., “Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?,” Chemotherapy Research and Practice, vol. 2010, Article ID 524629, 8 pages, 2010. doi:10.1155/2010/524629